“Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study”, J of Skin, vol. 2, p. S64, Dec. 2018, doi: 10.25251/skin.2.supp.64.